Used in the synthesis of pharmaceutical intermediates, particularly in developing drugs targeting neurological and cardiovascular conditions. Its structure supports the creation of bioactive molecules due to the presence of both ester and hydroxyl functional groups, enabling further chemical modifications. Commonly employed in research settings for designing novel nicotinate derivatives with potential therapeutic effects. Also explored in prodrug formulations to enhance drug delivery and bioavailability.